retatrutide clinical trials efficacy (RETA) is one of the most promising investigational peptides in obesity research— This weight-loss drug hasn't been

20 High-calorie diets Overconsumption of sugar-sweetened beverages containing sucrose or high-fructose corn syrup is associated with increased visceral fat, fatty liver, and steatohepatitis

The Lactobacillus delbrueckii Surge : Fecal metagenomic sequencing unmasked that Lactobacillus delbrueckii was the single most significantly increased microbial species following liraglutide treatment

Improved Metabolic Health Researchers are also studying retatrutide for: insulin sensitivity blood sugar regulation waist circumference metabolic syndrome markers Because obesity is closely linked to cardiovascular and metabolic disease risk, these broader improvements may become an important part of its long term clinical role

Animal studies have shown that GLP-1RAs activate fat cell browning and may regulate BAT through the central nervous system